title: Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving Vedolizumab.
authors.affiliation: University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
authors.forename: Alana
authors.initials: A
authors.lastname: Wichmann
authors.affiliation: University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
authors.forename: Noa
authors.initials: N
authors.lastname: Krugliak Cleveland
authors.affiliation: University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
authors.forename: David T
authors.initials: DT
authors.lastname: Rubin
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008457:Measles / Q000517:prevention & control*; D022542:Measles-Mumps-Rubella Vaccine / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; D022542:Measles-Mumps-Rubella Vaccine; C543529:vedolizumab